Encompass Health Director Receives Dividend-Related RSU Grant
Encompass Health Corp
Subscribe to track EHC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing: Encompass Health Corp ($EHC) Insider: Leslye G. Katz (Director) Type: Acquisition (Award) | Shares: 81 @ $0.00 Value: $0.00 (Dividend equivalent RSUs) Post-Transaction Holdings: 49,724 shares Significance: Low (Routine dividend reinvestment into RSUs)
Comprehensive Analysis
Executive Summary
On October 19, 2026, Encompass Health Corp ($EHC) filed a Form 4 disclosing that Director Leslye G. Katz acquired 81 shares of common stock in the form of restricted stock units (RSUs) on October 15, 2026. Following this transaction, Katz beneficially owns 49,724 shares directly.
Transaction Details
- Security: Encompass Health Common Stock
- Transaction Code: A (Award/Grant)
- Shares Acquired: 81
- Price per Share: $0.00
- Total Transaction Value: $0.00 (notional value of approximately $10,349 based on the $127.77 closing price on the payment date)
Context and Analysis
According to the filing footnotes, the acquisition was not an open-market purchase or discretionary compensation grant. Instead, it was an automatic crediting of additional RSUs pursuant to existing award agreements for non-employee directors in connection with Encompass Health's quarterly dividend of $0.21 per share paid on October 15, 2026. The number of credited units was determined by dividing the dividend amount payable on existing RSUs by the closing price of $127.77.
Market Significance
This transaction carries Low significance for investors. It represents an automatic, formulaic dividend reinvestment feature of director equity awards rather than discretionary insider sentiment or a shift in operational confidence.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
